ArticleJournal of cancer research and clinical oncology2023
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy.
Jaewon Hyung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.